Loading clinical trials...
Loading clinical trials...
Validation of Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer: A Feasibility Study
Conditions
Locations
1
Israel
Barzilai University Medical Center
Ashkelon, Israel
Start Date
January 20, 2025
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
March 26, 2025
NCT05671510
NCT03340506
NCT06476808
NCT07361497
NCT07510724
NCT07485114
Lead Sponsor
Barzilai Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions